2 Healthcare Stocks That Could Join the $1 Trillion Club by 2033

There's no healthcare company that's worth anywhere near $1 trillion today. But within the next 10 years, that's likely to change, given the many growth opportunities emerging in the industry. Two companies that I can see eclipsing $1 trillion by 2033 are Eli Lilly (NYSE: LLY) and UnitedHealth Group (NYSE: UNH). Here's why these stocks could deliver some fantastic returns for investors in the long run.

Eli Lilly's market capitalization is at $425 billion today. To reach the $1 trillion mark, it would need to rise by 135% in value. That may seem like a lot, but to do that over a period of 10 years would only require it to achieve a compound annual growth rate of around 8.9%. And given the products the company has in its pipeline and the growth they might achieve, that's not an outlandish prospect.

One big opportunity for the company is in weight loss, where Eli Lilly has not just one but multiple promising products. Diabetes drug Mounjaro has shown encouraging results in clinical trials as a weight loss aid. Among the cohort taking the highest prescribed dose in a phase 3 study, participants lost an average of 22.5% of their body weight over a 72-week period.

Continue reading

Source Fool.com